======= HNRNPA0 ======= == Gene Information == * **Official Symbol**: HNRNPA0 * **Official Name**: heterogeneous nuclear ribonucleoprotein A0 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10949|10949]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q13151|Q13151]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HNRNPA0&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HNRNPA0|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609409|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: mRNA-binding component of ribonucleosomes. Specifically binds AU-rich element (ARE)-containing mRNAs. Involved in post- transcriptional regulation of cytokines mRNAs. {ECO:0000269|PubMed:12456657}. |RRM 1| |AU-rich element binding| |3-UTR-mediated mRNA stabilization| |mRNA 3-UTR AU-rich region binding| |mRNA stabilization| |RNA stabilization| |negative regulation of mRNA catabolic process| |negative regulation of RNA catabolic process| |negative regulation of mRNA metabolic process| |ribonucleoprotein complex| |mRNA binding| |regulation of mRNA stability| |regulation of RNA stability| |regulation of mRNA catabolic process| |negative regulation of cellular catabolic process| |mRNA splicing, via spliceosome| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |RNA splicing, via transesterification reactions| |negative regulation of catabolic process| |response to lipopolysaccharide| |response to molecule of bacterial origin| |regulation of mRNA metabolic process| |RNA splicing| |protein kinase binding| |mRNA processing| |inflammatory response| |posttranscriptional regulation of gene expression| |response to bacterium| |mRNA metabolic process| |regulation of cellular catabolic process| |response to lipid| |RNA processing| |regulation of catabolic process| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |negative regulation of RNA metabolic process| |defense response| |RNA binding| |negative regulation of nucleobase-containing compound metabolic process| |response to oxygen-containing compound| |RNA metabolic process| |positive regulation of gene expression| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp20|Etoposide 10μM R00 exp20]]|-2.87| |[[:results:exp33|Rotenone 2μM R00 exp33]]|-2.54| |[[:results:exp143|Phenformin 20μM R03 exp143]]|-2.14| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|-2.12| |[[:results:exp134|MS023 2μM R03 exp134]]|-2.1| |[[:results:exp19|Etoposide 1μM R00 exp19]]|-1.94| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|-1.82| |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|-1.76| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|1.72| |[[:results:exp477|DKK1 89ng/ml R08 exp477]]|1.82| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|1.84| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|1.86| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|2.66| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 3/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|1/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|1/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18927 * **Expression level (log2 read counts)**: 8.14 {{:chemogenomics:nalm6 dist.png?nolink |}}